通过整合多种基因组数据以通路为导向识别癌症亚组的贝叶斯框架
提出Bayes-InGRiD,一种通路导向的贝叶斯稀疏潜因子模型,在统一框架内基于连续、二分类和计数数据的联合分析,同时识别癌症患者亚组(聚类)和关键分子特征(变量选择)。利用通路(基因集)信息提高识别准确性和稳健性并促进生物学解释,提出Pólya-Gamma混合表示下的替代Gibbs采样器实现高效后验采样,R包INGRID已可获取。
要点
- Bayes-InGRiD可同时进行癌症患者亚组聚类和关键分子特征变量选择。
- 模型整合连续、二分类和计数三类基因组数据并利用通路信息。
- 提出Pólya-Gamma混合的替代Gibbs采样器实现高效后验采样。
核心结论
- Bayes-InGRiD利用通路信息不仅提高癌症患者亚组和关键分子特征识别的准确性与稳健性,还促进生物学理解与解释。
研究设计与样本
- 提出Bayes-InGRiD,一种通路导向的贝叶斯稀疏潜因子模型,基于连续、二分类和计数数据的联合分析,在统一框架内同时识别癌症患者亚组(聚类)和关键分子特征(变量选择)。
主要发现
- Bayes-InGRiD利用通路(基因集)信息提高癌症患者亚组和关键分子特征识别的准确性与稳健性,并促进生物学理解与解释。
- 提出使用Pólya-Gamma正态混合表示二分类和计数数据潜变量的替代Gibbs采样器,实现高效后验采样并产生后验的条件高斯表示。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In recent years, comprehensive cancer genomics platforms, such as The Cancer Genome Atlas (TCGA), provide access to an enormous amount of high throughput genomic datasets for each patient, including gene expression, DNA copy number alterations, DNA methylation, and somatic mutation. While the integration of these multi-omics datasets has the potential to provide novel insights that can lead to personalized medicine, most existing approaches only focus on gene-level analysis and lack the ability to facilitate biological findings at the pathway-level. In this article, we propose Bayes-InGRiD (Bayesian Integrative Genomics Robust iDentification of cancer subgroups), a novel pathway-guided Bayesian sparse latent factor model for the simultaneous identification of cancer patient subgroups (clustering) and key molecular features (variable selection) within a unified framework, based on the joint analysis of continuous, binary, and count data. By utilizing pathway (gene set) information, Bayes-InGRiD does not only enhance the accuracy and robustness of cancer patient subgroup and key molecular feature identification, but also promotes biological understanding and interpretation. Finally, to facilitate an efficient posterior sampling, an alternative Gibbs sampler for logistic and negative binomial models is proposed using Pólya-Gamma mixtures of normal to represent latent variables for binary and count data, which yields a conditionally Gaussian representation of the posterior. The R package "INGRID" implementing the proposed approach is currently available in our research group GitHub webpage (https://dongjunchung.github.io/INGRID/).
引用
- Sun Z, Chung D, Neelon B, et al. A Bayesian framework for pathway-guided identification of cancer subgroups by integrating multiple types of genomic data. Stat Med. 2023. PMID: 37715500. doi:10.1002/sim.9911
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。